Total Valuation
Biostax has a market cap or net worth of $7.87K. The enterprise value is $1.11M.
Market Cap$7.87K
Enterprise Value$1.11M
Share Statistics
Biostax has 78,713,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding78,713,630
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biostax’s return on equity (ROE) is 0.52 and return on invested capital (ROIC) is 43.69%.
Return on Equity (ROE)0.52
Return on Assets (ROA)-66.96
Return on Invested Capital (ROIC)43.69%
Return on Capital Employed (ROCE)0.33
Revenue Per Employee0.00
Profits Per Employee-590.66K
Employee Count4
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Biostax is ―. Biostax’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow-0.02
PEG Ratio0.00
Income Statement
In the last 12 months, Biostax had revenue of 0.00 and earned -2.36M in profits. Earnings per share was -0.03.
Revenue0.00
Gross Profit0.00
Operating Income-1.48M
Pretax Income-2.36M
Net Income-2.36M
EBITDA-2.14M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -33.31K and capital expenditures 0.00, giving a free cash flow of -33.31K billion.
Operating Cash Flow-33.31K
Free Cash Flow-33.31K
Free Cash Flow per Share>-0.01
Dividends & Yields
Biostax pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.59
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Biostax upcoming earnings date is May 15, 2018, During Market Hours (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateMay 15, 2018
Ex-Dividend Date―
Financial Position
Biostax as a current ratio of ―, with Debt / Equity ratio of -24.94%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA-0.51
Interest Coverage Ratio―
Taxes
In the past 12 months, Biostax has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Biostax EV to EBITDA ratio is -3.25, with an EV/FCF ratio of -17.03.
EV to Sales0.00
EV to EBITDA-3.25
EV to Free Cash Flow-17.03
EV to Operating Cash Flow-17.03
Balance Sheet
Biostax has $2.10K in cash and marketable securities with $1.24M in debt, giving a net cash position of -$1.24M billion.
Cash & Marketable Securities$2.10K
Total Debt$1.24M
Net Cash-$1.24M
Net Cash Per Share-$0.02
Tangible Book Value Per Share―
Margins
Gross margin is 0.00%, with operating margin of ―, and net profit margin of ―.
Gross Margin0.00%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Biostax is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―